SEC Filing Madrigal Pharmaceuticals.
$ 17.50 · 4.5 (120) · In stock
SEC Filing NeuroBo Pharmaceuticals, Inc.
Deutsche Bank AG Purchases 6,840 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)
B. Riley Securities Downgrades Madrigal Pharmaceuticals (MDGL)
Breaking: FDA approves Madrigal's Rezdiffra as first MASH therapy - BioSpace
SEC Filing Kiniksa Pharmaceuticals
Madrigal Pharmaceuticals (MDGL) 10K Form and SEC Filings 2024
Madrigal Pharmaceuticals Inc - DEF 14A - Proxy Statement - May 01, 2023
Madrigal Pharmaceuticals launches $500 million stock offering By Investing.com
Quidel Corp Says Increased Size Of Board To Eight Members - SEC Filing